Literature DB >> 29939802

Update on trends in varicella mortality during the varicella vaccine era-United States, 1990-2016.

Jessica Leung, Mona Marin1.   

Abstract

We reported previously that the annual average mortality rate in the United States in 2008-2011 for varicella listed as the underlying cause declined 87% compared with the prevaccine period (1990-1994). Here, we update the analysis with five additional years of data. We used varicella death data from the 2012-2016 Mortality Multiple Cause-of Death records to calculate mortality rates during 2012-2016 and trends since the prevaccine period and end of 1-dose vaccination program (2005-2007). The annual average age-adjusted mortality rate for varicella as the underlying cause was 0.03 per million population during 2012-2016, a 94% reduction from prevaccine years and a 47% reduction from 2005-2007. Varicella deaths continue to decline due to the varicella vaccination program in the United States.

Entities:  

Keywords:  CDC; NCHS; VZV; surveillance; vaccine-preventable disease; varicella deaths; varicella mortality; varicella vaccine

Mesh:

Substances:

Year:  2018        PMID: 29939802      PMCID: PMC6284515          DOI: 10.1080/21645515.2018.1480283

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  13 in total

1.  Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era.

Authors:  Adriana S Lopez; John Zhang; Cedric Brown; Stephanie Bialek
Journal:  Pediatrics       Date:  2011-01-03       Impact factor: 7.124

2.  Impact of the Maturing Varicella Vaccination Program on Varicella and Related Outcomes in the United States: 1994-2012.

Authors:  Jessica Leung; Rafael Harpaz
Journal:  J Pediatric Infect Dis Soc       Date:  2015-08-12       Impact factor: 3.164

3.  Near elimination of varicella deaths in the US after implementation of the vaccination program.

Authors:  Mona Marin; John X Zhang; Jane F Seward
Journal:  Pediatrics       Date:  2011-07-25       Impact factor: 7.124

4.  Epidemiology of Varicella During the 2-Dose Varicella Vaccination Program - United States, 2005-2014.

Authors:  Adriana S Lopez; John Zhang; Mona Marin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-09-02       Impact factor: 17.586

5.  Trends in varicella mortality in the United States: Data from vital statistics and the national surveillance system.

Authors:  Jessica Leung; Stephanie R Bialek; Mona Marin
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Impact of a routine two-dose varicella vaccination program on varicella epidemiology.

Authors:  Stephanie R Bialek; Dana Perella; John Zhang; Laurene Mascola; Kendra Viner; Christina Jackson; Adriana S Lopez; Barbara Watson; Rachel Civen
Journal:  Pediatrics       Date:  2013-10-07       Impact factor: 7.124

7.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Mona Marin; Dalya Güris; Sandra S Chaves; Scott Schmid; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2007-06-22

8.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.

Authors:  Tanja Y Walker; Laurie D Elam-Evans; James A Singleton; David Yankey; Lauri E Markowitz; Benjamin Fredua; Charnetta L Williams; Sarah A Meyer; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-08-25       Impact factor: 17.586

9.  Vaccination Coverage Among Children Aged 19-35 Months - United States, 2016.

Authors:  Holly A Hill; Laurie D Elam-Evans; David Yankey; James A Singleton; Yoonjae Kang
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-11-03       Impact factor: 17.586

Review 10.  Global Varicella Vaccine Effectiveness: A Meta-analysis.

Authors:  Mona Marin; Melanie Marti; Anita Kambhampati; Stanley M Jeram; Jane F Seward
Journal:  Pediatrics       Date:  2016-02-16       Impact factor: 7.124

View more
  10 in total

1.  Varicella vaccine strain infection in a non-immunocompromised patient. A case report and review of literature.

Authors:  Rana Swed-Tobia; Imad Kassis; Suhair Hanna; Moran Szwarcwort-Cohen; Sara Dovrat; Halima Dabaja-Younis
Journal:  Hum Vaccin Immunother       Date:  2020-09-18       Impact factor: 3.452

Review 2.  Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review.

Authors:  Mona Marin; Jessica Leung; Anne A Gershon
Journal:  Pediatrics       Date:  2019-09       Impact factor: 7.124

3.  Vaccine Strain and Wild-Type Clades of Varicella-Zoster Virus in Central Nervous System and Non-CNS Disease, New York State, 2004-2019.

Authors:  Patrick Bryant; Tugba Yildirim; Sara B Griesemer; Kara Shaw; Dylan Ehrbar; Kirsten St George
Journal:  J Clin Microbiol       Date:  2022-03-24       Impact factor: 11.677

4.  Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data.

Authors:  Meredith Woodward; Ann Marko; Susan Galea; Barry Eagel; Walter Straus
Journal:  Open Forum Infect Dis       Date:  2019-08-01       Impact factor: 3.835

Review 5.  Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination.

Authors:  Nathan B Price; Charles Grose
Journal:  Vaccines (Basel)       Date:  2021-01-06

6.  Meningitis Caused by the Live Varicella Vaccine Virus: Metagenomic Next Generation Sequencing, Immunology Exome Sequencing and Cytokine Multiplex Profiling.

Authors:  Prashanth S Ramachandran; Michael R Wilson; Gaud Catho; Geraldine Blanchard-Rohner; Nicoline Schiess; Randall J Cohrs; David Boutolleau; Sonia Burrel; Tetsushi Yoshikawa; Anne Wapniarski; Ethan H Heusel; John E Carpenter; Wallen Jackson; Bradley A Ford; Charles Grose
Journal:  Viruses       Date:  2021-11-16       Impact factor: 5.048

7.  Looking ahead: Caregivers' COVID-19 vaccination intention for children 5 years old and younger using the health belief model.

Authors:  Morgan E Ellithorpe; Fashina Aladé; Robyn B Adams; Glen J Nowak
Journal:  Vaccine       Date:  2022-02-01       Impact factor: 3.641

Review 8.  Varicella-zoster virus post-exposure management and prophylaxis: A review.

Authors:  Anne M Lachiewicz; Megan L Srinivas
Journal:  Prev Med Rep       Date:  2019-11-06

9.  Varicella Vaccine Meningitis as a Complication of Herpes Zoster in Twice-Immunized Immunocompetent Adolescents.

Authors:  Veena Ramachandran; Stephen C Elliott; Kathie L Rogers; Randall J Cohrs; Miles Weinberger; Wallen Jackson; John E Carpenter; Charles Grose; Daniel J Bonthius
Journal:  J Child Neurol       Date:  2020-07-17       Impact factor: 1.987

Review 10.  Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus.

Authors:  Ethan H Heusel; Charles Grose
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.